Founded in 1993, ACGT is a DNA sequencing and molecular biology provider with services in high throughput Sanger sequencing, NGS and genomics, bioinformatics, genotyping, qPCR, cDNA library construction and more. With two locations in the Chicago north suburbs and the Washington, D.C. metro area, our facilities are CLIA accredited by the College of American Pathologists (CAP) and our services are offered at a standard research level, regulatory GLP or cGMP compliant, and clinical grade. Our clientele consists of life science researchers from academic institutions, biotech companies and drug developers and public health agencies. For more information visit us at www.acgtinc.com or you may contact us at 1.800.557.2248.
Quintara Biosciences specializes in providing high quality DNA sequencing and genomic services for life science research communities around the world. With labs located in MA, CA, CO, CT, NJ, and DC, we are poised and ready to help scientists move their research forward.
Nucleome Informatics Pvt Ltd is a deep tech driven genomics enterprise to discover, innovate, and develop products. Headquartered in Hyderabad, we are building one of India’s most advanced genomics ecosystems by combining high-resolution sequencing, multi-omics, advanced bioinformatics, and AI-driven analytics to decode genomes and deliver transformative applications.
Our vision is to place India at the forefront of the genomics revolution, while our mission is to harness the power of genomes to improve healthcare, strengthen agriculture, and advance scientific discovery.
We operate through three specialized verticals:
DrSeq – our human genomics vertical focused on healthcare and clinical NGS, developing solutions for early cancer detection, rare disease diagnostics, therapy selection, and precision medicine.
DrSeed – our agricultural genomics platform supporting the seed industry through molecular breeding, trait discovery, genomic selection, and development of climate-resilient crops.
DrPAM – our academic genomics and research vertical providing advanced genomics infrastructure, AI-powered bioinformatics, and collaborative solutions to enable large-scale discovery in life sciences.
By integrating genomics technologies with AI-powered data interpretation, Nucleome delivers actionable insights across oncology, rare diseases, agriculture, and biodiversity conservation. Our approach enables complex variant detection, population genomics, and predictive analytics at a scale unmatched in the region.
As a recognized leader, we partner with national initiatives, global consortia, academic institutions, and industry innovators to drive impactful collaborations. Looking ahead, we are expanding AI-driven clinical solutions, building large population reference datasets, and accelerating translational genomics for healthcare, agriculture, and research. At our core, we believe the future of science and society is written in genomes. At Nucleome, we are decoding it.